Efficacy of Pre-sleep or Post-exercise Protein During 12 Weeks of Resistance Exercise Training

Last updated: June 25, 2023
Sponsor: Florida State University
Overall Status: Completed

Phase

N/A

Condition

Aging

Treatment

Protein

Placebo

Clinical Study ID

NCT05922475
25996
  • Ages 60-75
  • Male
  • Accepts Healthy Volunteers

Study Summary

The goal of this clinical trial is to compare the effects of protein consumption before sleep or immediately after exercise during 12 weeks of resistance exercise training in older adults. The main questions it aims to answer are:

Are there differences in muscle growth or strength during 12 weeks of resistance training when 40 grams of protein is consumed either before sleep or immediately after exercise? Are there differences in cognitive performance during 12 weeks of resistance training when 40 grams of protein is consumed either before sleep or immediately after exercise?

This study is a randomized double-blind placebo-controlled study. Participants will be randomly allocated into 1 of 3 groups. All three groups will perform the same 12-week resistance exercise training program two times per week and consume 40 g of protein: 1) Immediately post-exercise, 2) 30 minutes prior to sleep, or 3) no supplemental protein (control). Test of muscle growth and strength, and cognitive performance will be measure before, during, and after the exercise training program.

Researchers will compare the 3 conditions to determine if consume protein after exercise or before sleep during 12 weeks of resistance exercise training affects muscle growth and strength, and cognitive performance.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Male between 60-75 years old at the time of enrollment.

Exclusion

Exclusion Criteria:

  • Diagnosis of cardiac or peripheral vascular disease
  • Stroke, kidney dysfunction
  • Metabolic disease
  • Uncontrolled hypertension
  • Orthopedic limitations
  • Skeletal muscle complications
  • Milk allergy
  • Psychiatric conditions
  • Use of psychotropic drugs
  • Cognitive impairment (scoring 26 points or less on the Montreal Cognitive Assessment)
  • Participation in a structured regular exercise program within the past 6 months
  • Actively attempting to increase or decrease body mass
  • Body mass index (BMI) of ≥ 35 kg/m2

Study Design

Total Participants: 32
Treatment Group(s): 2
Primary Treatment: Protein
Phase:
Study Start date:
September 27, 2017
Estimated Completion Date:
May 03, 2019

Connect with a study center

  • Florida State University

    Tallahassee, Florida 32306
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.